TAG / FDA

After decades of warnings from watchdogs and researchers, the psychiatric establishment finally acknowledges that stopping SSRIs can trigger debilitating physical and mental effects.

The peer‑reviewed analysis reveals that psychotropics have failed to produce benefit for patients even as their use has surged and serious risks accumulate, prompting calls for regulatory overhaul.

A new large-scale study scrutinizing psychiatric prescribing finds clinicians continue to give high-risk drugs to Medicare dementia patients—most of the time with no documented justification at all.

Researchers tracked more than 1,000 Australian infants and found children whose mothers used antidepressants in the last three months of pregnancy had up to nine times higher odds of developing autism.

The Citizens Commission on Human Rights says FDA approval of antidepressants ignores decades of documented, permanent harms and calls for a full independent investigation into PSSD.

Federal courts, costly class action litigation and safety alerts haven’t stopped Botanic Tonics from selling $250 million a year of a product that leaves addicts warning, “I thought I was going to die.”

A surge in overdoses tied to the synthetic compound 7-OH has triggered emergency action in Los Angeles County. Regulators warn that products sold as natural remedies mask opioid-like disasters.

Factors like sex, race or foster care status didn’t explain the fivefold jump in psychotropic stacking. The results expose a system primed to drug children rather than help them.

From smoke shops to health food stores, highly addictive kratom formulas exploit legal loopholes, putting communities across the US in danger.

A landmark reform shuts down deceptive drug ads that fueled overprescribing, misinformation and billions in profits for Big Pharma.